CD8A and neoplasm: The discovery of the CNS lymphatic system, and previous demonstration of potential trafficking and recruitment of CD8+ T cells to the brain tissue following from PD‐1/CTLA‐4 inhibition may shed new light on the mechanism by which CAR‐T could target GBM tumor cells within the brain microenvironment.71